Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5944011 | Atherosclerosis | 2015 | 8 Pages |
Abstract
Atheroprotective mbHSP65 peptides may be considered as potential candidates for the development of a tolerizing vaccine to prevent and treat atherosclerosis, while keeping protective immunity to non-atherogenic domains of mbHSP65 intact.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Cecilia Grundtman, Bojana Jakic, Maja Buszko, Elisabeth Onestingel, Giovanni Almanzar, Egon Demetz, Hermann Dietrich, Giuseppe Cappellano, Georg Wick,